Calcium plays a vital role in various physiological processes, including bone metabolism. This article aims to provide an in-depth understanding of the importance of calcium in bone health and disease, aiding healthcare professionals in their clinical practice.
Calcium is the primary mineral found in bones and teeth, accounting for about 99% of the body's total calcium. It is essential for the process of bone mineralization, where it combines with phosphorus to form hydroxyapatite crystals, providing strength and rigidity to the skeletal structure.
Bone remodeling is a continuous process of bone formation and resorption, maintaining skeletal health. Calcium plays a crucial role in this process. Osteoblasts, the bone-forming cells, require calcium for the production of bone matrix, while osteoclasts, the bone-resorbing cells, release calcium from the bone into the bloodstream, maintaining calcium homeostasis.
Calcium homeostasis is tightly regulated by hormones like parathyroid hormone (PTH), calcitonin, and vitamin D. PTH increases blood calcium levels by enhancing bone resorption, renal calcium reabsorption, and intestinal calcium absorption. Calcitonin reduces blood calcium levels by inhibiting osteoclast activity. Meanwhile, vitamin D facilitates calcium absorption from the gut.
Calcium deficiency can lead to bone diseases like osteoporosis and rickets. Osteoporosis, characterized by reduced bone mass and increased fracture risk, is often caused by inadequate calcium intake or impaired calcium absorption. Rickets, a childhood disease, results from severe vitamin D and calcium deficiency, leading to soft and deformed bones.
Understanding the role of calcium in bone metabolism is crucial for healthcare professionals. It aids in the prevention, diagnosis, and treatment of bone diseases. Ensuring adequate calcium intake and absorption, and understanding its hormonal regulation, are key to maintaining optimal bone health.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation